David Kirske
Financieel Directeur/CFO bij CTI BIOPHARMA CORP.
Actieve functies van David Kirske
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CTI BIOPHARMA CORP. | Financieel Directeur/CFO | 26-09-2017 | - |
| Bedrijfssecretaris | - | - |
Loopbaan van David Kirske
Eerdere bekende functies van David Kirske
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| HELIX BIOMEDIX, INC. | Financieel Directeur/CFO | - | 23-06-2008 |
| Redhook Ale Brewery, Inc. | Comptroller/Controller/Auditor | - | - |
| Treasurer | - | - | |
| F5, INC. | Comptroller/Controller/Auditor | - | - |
| Treasurer | - | - |
Opleiding van David Kirske
| University of Puget Sound | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
| Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| HELIX BIOMEDIX, INC. | Health Technology |
| F5, INC. | Technology Services |
| Bedrijven in privébezit | 2 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
| Redhook Ale Brewery, Inc. | Consumer Non-Durables |
- Beurs
- Insiders
- David Kirske
- Ervaring